Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes

American Journal of Clinical Nutrition

Volumn 99, Issue 1, 2014, Pages 79-85

  Mahendran, Yuvaraj ^a   Ågren, Jyrki ^b   Uusitupa, Matti ^a,b   Cederberg, Henna ^a   Vangipurapu, Jagadish ^a   Stančáková, Alena ^a   Schwab, Ursula ^b   Kuusisto, Johanna ^a   Laakso, Markku ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; ADRENIC ACID; ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; ERYTHROCYTE MEMBRANE FATTY ACID; FATTY ACID; GLUCOSE; INSULIN; LINOLEIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; PALMITIC ACID; PALMITOLEIC ACID; STEARIC ACID; UNCLASSIFIED DRUG; VACCENIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; FINLAND; FOLLOW UP; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POPULATION BASED CASE CONTROL STUDY; PREDICTIVE VALUE; PREDICTOR VARIABLE; PROSPECTIVE STUDY;

EID: 84891462249     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.069740     Document Type: Article

References (39)

1. Skeaff CM, Hodson L, McKenzie JE. Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. J Nutr 2006;136:565-9.
2. Lemaitre RN, King IB, Sotoodehnia N, Knopp RH, Mozaffarian D, McKnight B, Rea TD, Rice K, Friedlander Y, Lumley TS, et al. Endogenous red blood cell membrane fatty acids and sudden cardiac arrest. Metabolism 2010;59:1029-34.
3. Arab L. Biomarkers of fat and fatty acid intake. J Nutr 2003;133:925S- 32S.
4. Sun Q, Ma J, Campos H, Hankinson SE, Hu FB. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 2007;86:74-81.
5. Fuhrman BJ, Barba M, Krogh V, Micheli A, Pala V, Lauria R, Chajes V, Riboli E, Sieri S, Berrino F, et al. Erythrocyte membrane phospholipid composition as a biomarker of dietary fat. Ann Nutr Metab 2006;50:95-102.
6. Vidgren HM, Agren JJ, Schwab U, Rissanen T, Hanninen O, Uusitupa MI. Incorporation of n23 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 1997;32:697-705.
7. Takkunen M, Agren J, Kuusisto J, Laakso M, Uusitupa M, Schwab U. Dietary fat in relation to erythrocyte fatty acid composition in men. Lipids (Epub ahead of print 24 August 2013).
8. Sarkkinen ES, Agren JJ, Ahola I, Ovaskainen ML, Uusitupa MI. Fatty acid composition of serum cholesterol esters, and erythrocyte and platelet membranes as indicators of long-term adherence to fat-modified diets. Am J Clin Nutr 1994;59:364-70.
9. Kröger J, Schulze MB. Recent insights into the relation of Delta5 desaturase and Delta6 desaturase activity to the development of type 2 diabetes. Curr Opin Lipidol 2012;23:4-10.
10. Nakamura MT, Nara TY. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr 2004;24:345-76.
11. Djoussé L, Matthan NR, Lichtenstein AH, Gaziano JM. Red blood cell membrane concentration of cis-palmitoleic and cis-vaccenic acids and risk of coronary heart disease. Am J Cardiol 2012;110:539-44.
12. Bjermo H, Riserus U. Role of hepatic desaturases in obesity-related metabolic disorders. Curr Opin Clin Nutr Metab Care 2010;13:703-8.
13. Kröger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, Doring F, Joost HG, Boeing H, Schulze MB. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2011;93: 127-42.
14. Brenner RR. Hormonal modulation of delta6 and delta5 desaturases: case of diabetes. Prostaglandins Leukot Essent Fatty Acids 2003;68: 151-62.
15. Tilvis RS, Helve E, Miettinen TA. Improvement of diabetic control by continuous subcutaneous insulin infusion therapy changes fatty acid composition of serum lipids and erythrocytes in type 1 (insulindependent) diabetes. Diabetologia 1986;29:690-4.
16. Tilvis RS, Taskinen MR, Miettinen TA. Effect of insulin treatment on fatty acids of plasma and erythrocyte membrane lipids in type 2 diabetes. Clin Chim Acta 1988;171:293-303.
17. Clifton PM, Nestel PJ. Relationship between plasma insulin and erythrocyte fatty acid composition. Prostaglandins Leukot Essent Fatty Acids 1998;59:191-4.
18. Agostoni C, Riva E, Bellu R, Vincenzo SS, Grazia BM, Giovannini M. Relationships between the fatty acid status and insulinemic indexes in obese children. Prostaglandins Leukot Essent Fatty Acids 1994;51: 317-21.
19. Vessby B, Ahren B, Warensjo E, Lindgarde F. Plasma lipid fatty acid composition, desaturase activities and insulin sensitivity in Amerindian women. Nutr Metab Cardiovasc Dis 2012;22:176-81.
20. Haag M, Dippenaar NG. Dietary fats, fatty acids and insulin resistance: short review of a multifaceted connection. Med Sci Monit 2005;11: RA359-67.
21. Ginsberg BH, Brown TJ, Simon I, Spector AA. Effect of the membrane lipid environment on the properties of insulin receptors. Diabetes 1981; 30:773-80.
22. De Gomez Dumm IN, De Alaniz MJ, Brenner RR. Effect of diet on linoleic acid desaturation and on some enzymes of carbohydrate metabolism. J Lipid Res 1970;11:96-101.
23. Taylor AJ, Jennings PE, Barnett AH, Pandov HI, Lawson N. An alternative explanation for the changes in erythrocyte fatty acids observed in diabetes mellitus. Clin Chem 1987;33:2083-5.
24. Allen HG, Allen JC, Boyd LC, Alston-Mills BP, Fenner GP. Determination of membrane lipid differences in insulin resistant diabetes mellitus type 2 in whites and blacks. Nutrition 2006;22:1096-102.
25. Bakan E, Yildirim A, Kurtul N, Polat MF, Dursun H, Cayir K. Effects of type 2 diabetes mellitus on plasma fatty acid composition and cholesterol content of erythrocyte and leukocyte membranes. Acta Diabetol 2006;43:109-13.
26. Peterson DB, Fisher K, Carter RD, Mann J. Fatty acid composition of erythrocytes and plasma triglyceride and cardiovascular risk in Asian diabetic patients. Lancet 1994;343:1528-30.
27. Pelikanova T, Kohout M, Valek J, Base J, Stefka Z. Fatty acid composition of serum lipids and erythrocyte membranes in type 2 (noninsulin-dependent) diabetic men. Metabolism 1991;40:175-180.
28. Tilvis RS, Miettinen TA. Fatty acid compositions of serum lipids, erythrocytes, and platelets in insulin-dependent diabetic women. J Clin Endocrinol Metab 1985;61:741-5.
29. Baldini P, Incerpi S, Lambert-Gardini S, Spinedi A, Luly P. Membrane lipid alterations and Na+-pumping activity in erythrocytes from IDDM and NIDDM subjects. Diabetes 1989;38:825-31.
30. Faas FH, Dang AQ, Kemp K, Norman J, Carter WJ. Red blood cell and plasma fatty acid composition in diabetes mellitus. Metabolism 1988; 37:711-3.
31. Krachler B, Norberg M, Eriksson JW, Hallmans G, Johansson I, Vessby B, Weinehall L, Lindahl B. Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2008;18:503-10.
32. Patel PS, Sharp SJ, Jansen E, Luben RN, Khaw KT, Wareham NJ, Forouhi NG. Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr 2010;92:1214-22.
33. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004;27(suppl 1):S15-35.
34. Stancáková A, Javorsky M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 2009;58:1212-21.
35. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-70.
36. Wallin A, Di Giuseppe D, Orsini N, Patel PS, Forouhi NG, Wolk A. Fish consumption, dietary long-chain n23 fatty acids, and risk of type 2 diabetes: systematic review and meta-analysis of prospective studies. Diabetes Care 2012;35:918-29.
37. Vessby B, Gustafsson IB, Tengblad S, Boberg M, Andersson A. Desaturation and elongation of Fatty acids and insulin action. Ann N Y Acad Sci 2002;967:183-95.
38. Corpeleijn E, Feskens EJ, Jansen EH, Mensink M, Saris WH, de Bruin TW, Blaak EE. Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study. Diabetologia 2006;49:2392-401.
39. Mahendran Y, Cederberg H, Vangipurapu J, Kangas AJ, Soininen P, Kuusisto J, Uusitupa M, Ala-Korpela M, Laakso M. Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men. Diabetes Care (Epub ahead of print 11 September 2013).